ARCHIVES

Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Review Planned Of 54 Deaths In First 60 Days On Studies.

June 22, 2001

NCI TO Issue RFA For Gene Therapy Studies; $20 Mil. Se-Aside Ok’d

January 10, 1992

Arizona Cancer Center Wins Core Grant Renewal

June 26, 2009

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

July 4, 1997

To Wage New War On Cancer, Advocates Plan A Campaign Inspired By Earth Day

October 31, 1997

In Brief: FDA Approves Two Alpha Interferons; Canellos to Give Schwartz Lecture At Scripps Meeting

June 13, 1986